GlassScriptPhysician profile
Roderick D Warren
NPI 1528083078
$15,350.06
in general payments reported to CMS, 2019-2025
40 companies · $1,283 in 2025
The $1,283 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.27 · 2020: $194 · 2021: $710 · 2022: $299 · 2023: $12K · 2024: $577 · 2025: $1,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $12K · Food and Beverage: $1,099 · Travel and Lodging: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $12,013.66 |
| Food and Beverage | $1,098.83 |
| Travel and Lodging | $947.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pentax of America, INC. | $12,013.66 | 2023 | Video Colonoscope |
| Olympus America INC. | $1,055.77 | 2025 | Endocapsule Recorder, 4k Camera Head, Medical Control Unit For Endosurgery Uces-4 |
| Abbvie INC. | $335.79 | 2020-2025 | Vraylar, Qulipta |
| Boston Scientific Corporation | $239.36 | 2024-2025 | Resolution 360 Clip, General - Embolics |
| Protega Pharmaceutials INC | $238.38 | 2024 | Roxybond |
| Amgen INC. | $169.27 | 2019-2024 | Prolia, Evenity |
| Endogastric Solutions, INC | $112.01 | 2021 | |
| Novo Nordisk INC | $101.25 | 2022-2024 | Wegovy |
| Abbott Laboratories | $91.93 | 2021-2022 | |
| Amarin Pharma, INC. | $87.11 | 2020-2021 | |
| Lilly USA, LLC | $79.82 | 2022-2025 | Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $70.63 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.73 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $59.79 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.14 | 2022-2024 | Xifaxan |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roderick Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.